Literature DB >> 3089832

Is amygdala kindling in rats a model for drug-resistant partial epilepsy?

W Löscher, R Jäckel, S J Czuczwar.   

Abstract

Amygdala-kindled female rats were used to compare the effects of seven antiepileptic drugs that are clinically used for treatment of partial epilepsy with complex symptomatology, on generalized seizures, focal seizures, or electrographic seizure activity at the focus. As a second approach of drug evaluation, drug effects on mean latency, severity, and duration of the seizures were determined. Anticonvulsant potencies obtained were compared with those determined in the maximal electroshock seizure test in female rats. Phenobarbital, phenytoin, carbamazepine, valproic acid, diazepam, clonazepam, but not primidone dose-dependently suppressed generalized motor seizures in kindled rats; however, except for the benzodiazepines, ED50S were substantially higher than those determined in the maximal electroshock seizure test. Compared with their effect on generalized motor seizures, all drugs were much less potent in blocking focal seizures and afterdischarges recorded from the amygdala. The data suggest that with respect to behavioral and pharmacologic characteristics of the amygdala kindling model, fully kindled rats may be a useful model for drug-resistant complex partial seizures with secondary generalization. Results of experiments with novel inhibitors of GABA uptake, which were inactive in the maximal electroshock seizure test but highly potent against kindled seizures, suggest that such drugs might be more effective than current antiepileptic drugs for treatment of partial epilepsy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089832     DOI: 10.1016/0014-4886(86)90160-3

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  17 in total

1.  Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model.

Authors:  Doodipala S Reddy; Michael A Rogawski
Journal:  Epilepsy Res       Date:  2010-02-20       Impact factor: 3.045

2.  Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats.

Authors:  D Hönack; C Rundfeldt; W Löscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

3.  Electrical, molecular and behavioral effects of interictal spiking in the rat.

Authors:  Daniel T Barkmeier; Danielle Senador; Karine Leclercq; Darshan Pai; Jing Hua; Nash N Boutros; Rafal M Kaminski; Jeffrey A Loeb
Journal:  Neurobiol Dis       Date:  2012-03-26       Impact factor: 5.996

4.  Interactions of excitatory amino acid antagonists with conventional antiepileptic drugs.

Authors:  S J Czuczwar; W A Turski; Z Kleinrok
Journal:  Metab Brain Dis       Date:  1996-06       Impact factor: 3.584

Review 5.  Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.

Authors:  Wolfgang Löscher
Journal:  Neurochem Res       Date:  2017-03-13       Impact factor: 3.996

Review 6.  Animal models of limbic epilepsies: what can they tell us?

Authors:  Douglas A Coulter; Dan C McIntyre; Wolfgang Löscher
Journal:  Brain Pathol       Date:  2002-04       Impact factor: 6.508

7.  High doses of memantine (1-amino-3,5-dimethyladamantane) induce seizures in kindled but not in non-kindled rats.

Authors:  W Löscher; D Hönack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

Review 8.  Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.

Authors:  W Löscher
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

Review 9.  The Search for New Screening Models of Pharmacoresistant Epilepsy: Is Induction of Acute Seizures in Epileptic Rodents a Suitable Approach?

Authors:  Wolfgang Löscher
Journal:  Neurochem Res       Date:  2016-08-08       Impact factor: 3.996

10.  Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.

Authors:  A Matagne; D-G Margineanu; B Kenda; P Michel; H Klitgaard
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.